Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Volkenandt

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|June 14, 2002
Cutaneous melanoma in childhood and adolescence: an analysis of 36 patientsMonika H Schmid-Wendtner, Carola Berking, Jens Baumert, et al.
Archives of Dermatology|August 17, 2005
Safe in the sun: low prevalence of sunburns and a high use of sun protection measures in Bavarian preschool childrenAlexander Steinmann, Bernhard Liebl, Helen Kalies, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanomaAstrid Friebe, Markus J Schwarz, Monika Schmid-Wendtner, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 8, 2009
The use of high-resolution ultrasonography for preoperative detection of metastases in sentinel lymph nodes of patients with cutaneous melanomaChristian Kunte, Theda Schuh, Julia Y Eberle, et al.
Brain, Behavior, and Immunity|August 28, 2004
Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alphaMartin Schaefer, Martin Horn, Folkhard Schmidt, et al.
Melanoma Research|June 8, 2010
Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanomaChristian Kunte, Till Geimer, Jens Baumert, et al.
Journal of the American Academy of Dermatology|February 15, 2011
Analysis of predictive factors for the outcome of complete lymph node dissection in melanoma patients with metastatic sentinel lymph nodesChristian Kunte, Till Geimer, Jens Baumert, et al.
Psychosomatics|November 6, 2010
Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanomaAstrid Friebe, Martin Horn, Folkhart Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2021
30 Jahre Arbeitsgemeinschaft Dermatologische Onkologie (ADO)Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2021
30 years German Dermatologic Cooperative Oncology Group (DeCOG)Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|June 14, 2002
Cutaneous melanoma in childhood and adolescence: an analysis of 36 patientsMonika H Schmid-Wendtner, Carola Berking, Jens Baumert, et al.
Archives of Dermatology|August 17, 2005
Safe in the sun: low prevalence of sunburns and a high use of sun protection measures in Bavarian preschool childrenAlexander Steinmann, Bernhard Liebl, Helen Kalies, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 7, 2007
Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanomaAstrid Friebe, Markus J Schwarz, Monika Schmid-Wendtner, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 8, 2009
The use of high-resolution ultrasonography for preoperative detection of metastases in sentinel lymph nodes of patients with cutaneous melanomaChristian Kunte, Theda Schuh, Julia Y Eberle, et al.
Brain, Behavior, and Immunity|August 28, 2004
Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alphaMartin Schaefer, Martin Horn, Folkhard Schmidt, et al.
Melanoma Research|June 8, 2010
Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanomaChristian Kunte, Till Geimer, Jens Baumert, et al.
Journal of the American Academy of Dermatology|February 15, 2011
Analysis of predictive factors for the outcome of complete lymph node dissection in melanoma patients with metastatic sentinel lymph nodesChristian Kunte, Till Geimer, Jens Baumert, et al.
Psychosomatics|November 6, 2010
Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanomaAstrid Friebe, Martin Horn, Folkhart Schmidt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2021
30 Jahre Arbeitsgemeinschaft Dermatologische Onkologie (ADO)Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 22, 2021
30 years German Dermatologic Cooperative Oncology Group (DeCOG)Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Pageof 4